Skip to content
Search

Latest Stories

RPS launches research e-learning modules for pharmacy professionals

The Royal Pharmaceutical Society (RPS) and the National Institute for Health Research (NIHR), supported by the Association of Pharmacy Technicians UK (APTUK), have launched the first e-learning module in a series for pharmacists and pharmacy technicians to develop their skills and knowledge in research.

A total of nine e-learning modules will be released by the end of 2022 to improve research awareness, knowledge and skills for pharmacists and pharmacy technicians with little or no experience of research or research opportunities.


The aim is to improve the capacity of pharmacy professionals to provide the evidence base to improve the practice of pharmacy and the health of the public. The modules cover:

  • What research is
  • How to turn ideas into a research project
  • Different research methods
  • Practical considerations when undertaking research

The e-learning modules will be accessible from their e-learning platform. Each module takes around 45 to 60 minutes to complete and they can be done as single episodes of learning, or as a full set.

RPS President Professor Claire Anderson said: “Many pharmacy professionals are rather daunted by getting involved in research. Indeed, we have heard from pharmacists undertaking our post-registration credentialing assessments that the Research domain can present a real challenge.

“However, we believe it’s important that all pharmacy professionals have the opportunity to engage in research activities, not only to develop professionally, but also to contribute to and build on the pharmacy evidence base. We hope these e-learning modules will give you the confidence to start getting involved in research activities as part of your day-to-day practice.”

Chief Pharmaceutical Officer for England, David Webb said: “These accessible e-learning modules offer a valuable opportunity for pharmacy professionals to learn more about contributing to, participating in and leading research – enabling a positive impact on patient care and professional skills and equipping pharmacists and pharmacy technicians for the future.”

President of the Association of Pharmacy Technicians UK, Claire Steele said: “This is a fantastic example of how partnership working can produce development opportunities for pharmacy professionals with a real focus on improving pharmacy practice and importantly benefiting our patients and communities.”

Director of Programmes and Impact at NIHR Academy, Dr Pete Thompson said: “The new online resources that will be generated from this initiative will provide opportunities to engage clinicians who may not have experience of research and allow them to gain new skills to enable them to feel more confident to engage with research and research opportunities.”

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less